Cellectis

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch Cellectis and buy or sell other stocks, ETFs, and their options commission-free!

About CLLS

Cellectis SA operates as a clinical stage biotechnological company, which engages in gene-editing platform to develop cell and gene therapies. The company was founded by David J. 

CEO
André Choulika
CEOAndré Choulika
Employees
222
Employees222
Headquarters
Paris, Ile-de-France
HeadquartersParis, Ile-de-France
Founded
1999
Founded1999
Employees
222
Employees222

CLLS Key Statistics

Market cap
116.59M
Market cap116.59M
Price-Earnings ratio
-2.50
Price-Earnings ratio-2.50
Dividend yield
Dividend yield
Average volume
52.27K
Average volume52.27K
High today
$1.65
High today$1.65
Low today
$1.57
Low today$1.57
Open price
$1.62
Open price$1.62
Volume
37.22K
Volume37.22K
52 Week high
$2.43
52 Week high$2.43
52 Week low
$1.10
52 Week low$1.10

Analyst ratings

71%

of 7 ratings
Buy
71.4%
Hold
28.6%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.